Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-28

FDA Approved: RANOLAZINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original application for ranolazine, enabling a generic version of the anti-anginal medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)